June 8, 2020 / 5:11 AM / a month ago

BRIEF-Relief Therapeutics And Neurorx Expand Clinical Trial Of RLF-100

June 8 (Reuters) - RELIEF THERAPEUTICS HOLDING SA:

* RELIEF THERAPEUTICS AND NEURORX EXPAND CLINICAL TRIAL OF RLF-100 TO ALL PATIENTS WITH CRITICAL COVID-19 AND RESPIRATORY FAILURE

* CLINICAL TRIAL TO ENROLL 144 PATIENTS TOTAL WITH EXPANSION TO ADDITIONAL SITES

* CLINICAL TRIAL EXPANDED TO PATIENTS TREATED WITH BOTH NONINVASIVE AND MECHANICAL VENTILATION IN CRITICAL COVID-19. Source text: bit.ly/3cGvpkn Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below